this link is dated April 2017 --> City of Hope physicians and scientists joined a multinational team in reporting the success of a phase II clinical trial of a novel drug against essential thrombocythemia (ET). ET patients make too many platelets (cells essential for blood clotting), which puts them at risk for abnormal clotting and bleeding. All 18 patients treated with the drug, imetelstat, exhibited decreased platelet levels, and 16 showed normalized blood cell counts.
City of Hope, Duarte, California – Combining Science with Soul to Create Miracles at a Comprehensive Cancer Center designated by the National Cancer Institute – An Interview with the Provost and Chief Scientific Officer of City of Hope, Steven T. Ros
City of Hope, Duarte, California – Combining Science with Soul to Create Miracles at a Comprehensive Cancer Center designated by the National Cancer Institute – An Interview with the Provost and Ch…
Here we go! This stock is a gold mine!
Charting indicates 6+ min by mid summer. Whaaaat!
Let's stay green, and close at the 52 week high of $3.15
Another technical positive happened yesterday..The 100 DMA (day moving average) at 2.30 crossed over the 200 DMA at 2.28 to the upside..Just another Bullish indicator that shows Geron is on a positive uptrend..
Everyone here knows my wife died of cancer yet larrytheliarjack, DDD and Woof insist on calling me she. I do not know what larrytheliarjack, DDD and Woof have against my wife or wemon in general but I all know where my wife is and we all know where larrytheliarjack, DDD and Woof are going. God has a special place for you boys that short cancer cure companies.
IMETELSTAT is a synthetically produced oligonucleotide which originates from a research & development collaboration with Geron in California.
The finished product is a treatment for myelofibrosis, a serious chronic cancer where the normal production of blood cells in the medulla is disturbed.
JSC Schaffhausen has prevailed within the scope of the corresponding selection process against external toll manufacturers and also internal sites. The key determining factor for this decision was the wide experience and solidly established process in the area of lyophilization and aseptic manufacturing of Parenteral at the Schaffhausen site and, above all, the proven high flexibility of product launches.
Currently the product is in the clinical phase. The manufacturing of clinical material as well as first the commercial batches will begin as of 2016/2017.
Can we quit with the narcissist show here once and for all? With exception to posting about GERN, remember GERN? GERN? That's why we are here!!! To post all things GERN. Not you and your finger-pointing-cheap-shot-below-the-belt waste of breath. GERN! Just GERN. Good or bad as long as it is GERN. Did I forget to mention GERN? Oh no? You reading this? GERN. Jeez...
Regarding the $ 6 dolla buyout, why wouldn't J&J roll the dice and just pay the cool 1 billion if they thought imet was a hit? Why would they want a repeat scenario of the PYCP debacle$$$$?
Not bashing but being a clear headed realist here. Save us another 2-3 year wait and save yourself $$$ and buyout gern. If I'm missing a technical or monetary angle here do tell
To my novice eyes a cup and handle is in the making.
super happy our opc1 cells that we all created have brought happiness to a family with spinal cord injury Thomas Okarma was ahead of his time imetelstat will prove just as effective thanks to every shareholder who helped fund this medicine
Would anybody disagree to a $ 1,000,000,000 buyout this morning?
emmerson, I see you've joined the JACKASS club.
WilliamW is ShORt
Willyboy! Get that pie out of your fat mouth! What the heck were you doing today? It was pie, wasn't it? We had them! All you had to do was keep posting and we could have brought this house down! I'm talking pushing this thing to ZERO by the end of trading today! Today was the day and you missed it because you were too busy shoving pie in your fat mouth! You FAILED US! Every day it's either pie or sausage, you fat pig! Us shorts are losing our shorts and you're busy getting fatter than Mama June! You can save us if you just post 100x a day and for heaven's sake keep your greasy grubby fingers off that pie and sausage! Now, GET TO WORK! Burn them calories you fattie! LMAO
Hello "fringe lunatics". It's me again. I still have my 102,650 shares and am back in a state of high hopes concerning the future of GERN and Imetelstat. I've been in several of these "states" before over the past several years, and am well versed in GERN's volatility. However, this time something seems different. I have a much more pronounced feeling of "UP" than "DOWN" when contemplating GERN's future. Time will tell..
Imetelstat is on a Priority List in the EU. Is Imetelstat the same with the FDA?
This could be the case because of pediatric concerns. The EU made a Waiver Decision for pediatrics in 2016. If you look at the rankings of the top five CT with the FDA for Imetelstat, 2 indications are for pediatrics. In fact the top rank is for pediatrics for brain tumors.
EmmieTurd why are you still posting here? The stock of Geron is OVER your $2.73 buy in price which you stated numerous times that you just wanted to get your money back and sell OUT OUT OUT of this fraud of a stock..Do you want to be taken at your word? You want to be trusted? Then sell OUT OUT OUT of this stock you labeled a "fraud" and stop posting here so that this board can better trust what you have to say..which will be nothing once you sell out..
Andrew muted successfully.
I don't know about y'all; but I've made a small fortune with Gern. Course', I started with a large fortune, but....